Joseph J.�Y. Sung

Research interests

Publications

• Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites

  Gut · 2020 · https://doi.org/10.1136/gutjnl-2019-319664

• Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

  Gut · 2020 · https://doi.org/10.1136/gutjnl-2020-322368

• Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer

  Gut · 2018 · https://doi.org/10.1136/gutjnl-2018-317178

• Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers

  Microbiome · 2018 · https://doi.org/10.1186/s40168-018-0451-2

• Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.01.009

• Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32448-0

• Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.04.022

• The Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies

  Gastroenterology · 2017 · https://doi.org/10.1016/s0016-5085(17)33292-4

• Colorectal cancer

  Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.65

• Colorectal cancer screening: a global overview of existing programmes

  Gut · 2015 · 10.1136/gutjnl-2014-309086

• Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

  Gut · 2015 · 10.1136/gutjnl-2015-309800

• Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

  Nature Genetics · 2015 · https://doi.org/10.1038/ng.3359

• Gut mucosal microbiome across stages of colorectal carcinogenesis

  Nature Communications · 2015 · https://doi.org/10.1038/ncomms9727

• Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study

  Gastroenterology · 2013 · https://doi.org/10.1053/j.gastro.2013.04.007

• Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study

  PLoS ONE · 2013 · https://doi.org/10.1371/journal.pone.0062885

• Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial

  Journal of Hepatology · 2013 · https://doi.org/10.1016/j.jhep.2013.04.013

• Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers

  Scandinavian Journal of Gastroenterology · 2012 · https://doi.org/10.3109/00365521.2011.645501

• Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.26.2675

• Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.

  PubMed · 2010 · https://doi.org/10.7326/0003-4819-152-1-201001050-00179

• Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease

  Hepatology · 2009 · 10.1002/hep.23312

• Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

  Gut · 2009 · 10.1136/gut.2008.167817

• Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B

  Journal of Viral Hepatitis · 2008 · https://doi.org/10.1111/j.1365-2893.2008.01037.x

• Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

  Alimentary Pharmacology & Therapeutics · 2008 · https://doi.org/10.1111/j.1365-2036.2008.03816.x

• High Viral Load and Hepatitis B Virus Subgenotype Ce Are Associated With Increased Risk of Hepatocellular Carcinoma

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.13.2043

• Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response

  Clinical Gastroenterology and Hepatology · 2007 · https://doi.org/10.1016/j.cgh.2007.09.005

• Omeprazole before Endoscopy in Patients with Gastrointestinal Bleeding

  New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa065703

• Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery

  Biomaterials · 2006 · 10.1016/j.biomaterials.2006.09.047

• Clopidogrel versus Aspirin and Esomeprazole to Prevent Recurrent Ulcer Bleeding

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa042087

• Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

  New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa033364

• Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

  Journal of Clinical Virology · 2004 · 10.1016/j.jcv.2004.07.006

• Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

  Clinical & Experimental Immunology · 2004 · 10.1111/j.1365-2249.2004.02415.x

• A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa030685

• Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis

  New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa021907

Current projects

No projects listed.